BAER is the sound induced farfield reflection of electrical events generated within the auditory pathway in its progressive path through the brainstem (1-3). Because neurons of the cochlear nuclei and inferior collicular nuclei are sensitive to bilirubin
group B (n = 5) received bilirubin in albumin; group C (n = 7) was asphyxiated and then received albumin; and group D (n = 19) was asphyxiated and received bilirubin in albumin. When compared with controT values, no changes in BAER occurred in groups A or B and only slight changes were found in group C. In group D, seven rats died and seven suffered a marked secondary deterioration of the BAER following recovery, a phenomenon that did not occur in group C (p = 0.02). Bilirubin toxicity appears to be responsible for the changes in BAER but prior asphyxia was necessary for this effect to occur. Because the changes that occurred in group D involved all four major waves, it is not possible to separate out a toxic effect of bilirubin, localized to the auditory nerve and the auditory pathway, from a generalized systemic effect which could cause attenuation of the entire response. The BAER may be useful, however, as a noninvasive means of identifying bilirubin toxicity in the newborn. injury (4, 5) and contribute to waveforms in the BAER, auditory evoked potentials might be useful in the detection of early bilirubin toxicity (6) (7) (8) .
In most animal species, hyperbilirubinemia alone fails to produce kernictems. However, when hyperbilirubinemia is accompanied by an additional insult to the central nervous system (such as asphyxia), kernicterus may occur (9-1 1). We examined the effect of hyperbilirubinemia on the BAER in the adult rat, in the presence and absence of asphyxia.
SUBJECTS AND METHODS
Adult male Hooded Long-Evans rats, weighing 252 to 429 g, were studied. Pentobarbital, 65 mg/kg body weight, was injected intraperitoneally for anesthesia. Blood gases and arterial blood pressure were measured via a femoral artery catheter. Intravenous injections of albumin or bilirubin in albumin were given via a catheter in the femoral vein. Temperatures were servocontrolled by means of a rectal probe and warming lamp. Tracheostomies were performed on all animals prior to mechanical ventilation with a Harvard Rodent Respirator no. 680. Tubocurarine, 2.5 to 3.0 mg/kg body weight, was injected intraperitoneally to minimize movement artifact on the evoked potential recording and arterial blood gases were maintained at established norms ( 1-21.
Far-field short-latency brainstem potentials were recorded from a vertex active needle electrode and a jaw needle electrode and amplified with a Grass P5l l J EEG amplifier bandpass filtered from 10 to 3000 Hz. Click stimuli of 0.1 ms and 65.1 dB (SPL) were presented to the left ear at 10 clicks per second using a radio earphone (Radio Shack, no. 33-174) driven by 100 ~s square pulses of constant polarity. KHz and averaged using a TransEra analog to digital converter interfaced to a Tektronix 4052 desktop graphics computer system. Stimulus amplitude was below threshold for binaural interaction. The right ear canal remained patent. A stable brainstem auditory evoked potential with four major components was recorded similar to those reported by Jewett and Romano (2) .
Absolute latencies are the intervals in msec from the onset of the auditory stimulus to each component peak. Amplitudes are the heights in microvolts measured from the baseline. Positivity of the vertex electrode relative to the jaw electrode was plotted upward (Figs. 1 to 3 ). The first two components of the BAER are positive waves with the second wave of greater amplitude. The third component is a biphasic wave with greater negative amplitude than positive amplitude. The fourth component is a positive wave with smaller amplitude than wave I or 11. Frequently the fourth component was followed by one or two additional waves of low positive amplitude (Fig. 1) . Three successive averages of responses to 200 click stimuli were superimposed for determination of amplitudes and latencies of the various component waves.
A control BAER was obtained on all rats after stabilization of the arterial blood gases. Following this, two rats received an intravenous infusion through the femoral vein of 25% bovine serum albumin, 10 ml/kg body weight (group A, Table 1 ). F~v e rats received the same volume of a solution of 7 mM bilirubin in albumin prepared as described by Levine Fig. 4 ). Twenty-six rats (groups C and D) were asphyxiated by turning off the respirator and clamping the inspiratory and expiratory tubing. From preliminary experiments, 4 rnin of asphyxia produced the maximum insult with the least mortality. Resuscitation by hyperventilation with 100% oxygen and external cardiac massage produced stable, normal blood gases within 15 min in surviving rats (Table 2) . During the first 3 min of asphyxia, seven of these rats received an intravenous infusion of 1.5 inM bovine serum albumin, 10 ml/kg/body weight (group C), while the other 19 received a similar volume of 7 rrlM bilirubin in albumin (group D , Fig. 4) . In groups A and B additional BAER recordings were obtained at 5, 15, 30, 45, and 60 min following the completion of the infusions. In groups C and D recordings were taken at similar intervals following the completion of the 4-min period of asphyxia.
Blood (0.4 to 0.5 ml) for determination of total plasma bilirubin levels was removed from the femoral artery catheter at 5, 15, 30, and 60 rnin following the completion of the asphysic period. Plasma bilirubin determinations were performed using the American Optical Bilirubinometer. Statistical analyses were performed using two sample or paired t tests and Fisher's exact test.
RESULTS
In the 26 asphyxiated rats (groups C and D, Tables 1 and 2 ) the BAER deteriorated during progressive asphyxia. Characteristically, there was a decrease in amplitudes and a prolongation of the absolute latencies of all wave components until by 4 rrlin the BAER was abolished in all animals (Fig. 2) . Abolition of fhe BAER always occurred when arterial blood pressure fell below 20 to 25 mm Hg irrespective of the arterial blood gas status. With successful resuscitation and the restoration of blood pressure, the BAER returned to control values within 15 rnin of completion of the asphyxic period. Following asphyxia, increases in wave amplitude (particularly wave 11) were noted occasionally. In group C the absolute latency of wave I increased 60 min after asphyxia from a mean control value of 1.02 to 1.12 ms ( p = 0.04, one tailed t test) but no other changes in latency were found in the other waves or at other times after recovery from asphyxia.
In the nonasphyxiated rats (groups A and B, Table 1 ) there were no changes in the BAER following infusion of albumin or bilirubin in albumin. In group C one rat could not be resuscitated, but in the other six rats the BAER returned to control values within 15 min of recovery from asphyxia.
Of the 19 rats who were asphyxiated and received bilirubin in albumin (group D, Table l), seven (37%) could not be resuscitated ( p = 0.27 versus group C). In the remaining 12 rats, the BAER returned to control values within 15 min. Seven of these 12 demonstrated a later, secondary deterioration, of the BAER with progressively decreasing amplitudes and prolonged absolute latencies of all the component waves (group D2). None of the rats in group C had a similar deterioration in BAER ( p = 0.02 versus group D). The secondary deterioration was first detec~.ed on the 30-min tracing following resuscitation, and by 60 min l.he amplitudes of most waves were frequently less than 50% of control values (Fig. 3 A to F) . Two rats had a flat BAER by 45 and 60 min, respectively. The rats that demonstrated the secondary deterioration of the BAER (group D2) did not differ from those that had no such change (group D l ) with respect to weight, temperature, blood pressure, serum bilirubin levels, or time of resuscitation. Blood gas values are shown in Table 2 . A groups D 1 and D2 are probably a reflection of Pcoz differences, as would be expected in acute respiratory acidosis.
There were no significant differences in amplitudes or latencies between groups A, B, and C (after recovery from asphyxia). In group D the amplitude of wave 1 was significantly lower at 5, 45, and 60 min following asphyxia than in group C ( p < 0.05) but no differences were found in wave 11. In groups B and D bilirubin was cleared from the rats during the 1-h observation period, and there were no significant differences in serum bilirubin concentrations (Fig. 4) .
During asphyxia, the EEG tracing flattened prior to the abolition of the BAER and reappeared only after the BAER was elicited again. However, the amplitude of the EEG tracing remained attenuated when compared with control amplitudes prior to asphyxia. 
CONTROL
At autopsy, the asphyxiated animals who received bilirubin, demonstrated yellow serous or slightly hemorrhagic fluid accumulations of the pleural and abdominal cavities. Petechiae were frequently seen on the heart, lungs, and mucosa of the gastrointestinal tract. Yellow pulmonary edema was almost universally seen and frequently collected in the respiratory tubing during the 1-h period. These systemic findings of bilirubin toxicity are similar to those reported by Rozdilsky and Olszewski (5) . In contrast, the rats who received only bilirubin (without asphyxia) demonstrated yellow body fluids without evidence of hemorrhage, petechiae, exudations, or pulmonary edema. In rats who had received bilirubin infusions, there was no obvious yellow staining of brain parenchyma in those autopsied. Unfortunately, the brains were not perfused prior to examination so that yellow staining would likely be missed (5). Progressive cerebral edema in humans has been shown to produce decreases in wave amplitudes and prolongation of latencies of all wave components (1 5, 2 1) and hypoxic-ischemic brain injury due to asphyxia produces cerebral edema (22, 23) . Rats in group C, who were asphyxiated but received no bilirubin, did not demonstrate a secondary deterioration in the BAER by the completion of the 1-h observation period. The presence of bilirubin was needed, in addition to the asphyxia1 insult, before a portion of the rats demonstrated a secondary progressive deterioration of their BAER. In the brains examined, there was no evidence of brainstem herniation or gross edema.
Low systemic arterial blood pressures alone (and, presumably, a decreased cerebral blood flow) could also account for such a deterioration. However, there were no differences detected in arterial blood pressures between those rats who demonstrated the secondary deterioration, and those who did not.
Three of the seven rats who demonstrated a secondary deterioration in the BAER, had a persistent acidosis following resuscitation. Two had metabolic acidosis and one a respiratory acidosis (pH 7.09, Pco, 72 torr). Bratlid et a/. (17) have shown that hypercarbia will open the blood brain barrier and allow bilirubin entry into the rat's brain whereas metabolic acidosis will not. Since six of the seven rats did not have hypercarbia in the recovery phase, this could not, by itself, account for the secondary deterioration seen in the BAER.
Hypothermia has been shown to prolong latencies and produce variable effects on amplitudes of the BAER (24) . Temperatures of all rats were servocontrolled and remained at control values.
When BAER testing has been attempted in patients with posticteric deafness, there was either no response or a response only to increased intensity of the click stimuli (25) , and deterioration of the BAER has been demonstrated in hyperbilirubinemic infants (6, 8, 26) . We do not know if the secondary progressive deterioraton seen in our study was permanent or would have improved over a longer observation time or with exchange transfusion.
We have shown that asphyxia can predispose the adult rat brain to the toxic effects of bilirubin, but we do not know if it is hypoxia, hypercarbia, the resulting hypotension and ischemia, or a combination of these factors that is responsible. Nevertheless, as has been shown by others (6, 8, 26 ) the BAER might be useful as a noninvasive means of identifying bilirubin toxicity.
